Learn how together we've lowered DNA rates and generated financial savings, while developing a solution that transforms how care is delivered.
Guy’s and St. Thomas’ is one of the UK’s leading foundation trusts, with 2 large central London hospitals, 2.3 million patient contacts, and 1.2 million outpatient appointments through their 1,000 inpatient beds per year.
Following a successful pilot primarily with the Women’s Services Department in 2015 (resulting in ‘Did Not Attend’ rate dropping by 30% and attendance rates improving – equivalent to an extra 2,440 patients over a year, and worth £317k profit), DrDoctor was implemented to all outpatients departments throughout the Trust beginning in April 2016.
DrDoctor created a bespoke training regime for each of the different roles and responsibilities tailored to the size and scale of the organisation. Each role was trained in a series of practical sessions run by the DrDoctor team, where the department were not only shown how to use the software but how to align their processes with the new system.
The DrDoctor functionality is grouped depending on session code, which gives super-users the ability to customise patient information to a high level of detail. During the go-live process, super-users were given the responsibility to customise and turn-on features at their discretion and shown the process to turn off the legacy reminder system. Weekly team meetings were held to feedback turn-on progress and early benefits.
At the end of the six-month onboarding phase, the DNA rates across the Trust dropped from 11.7% to 10.4% (11.1% reduction).
Guy’s and St. Thomas’ internal reporting has calculated the 2016/17 full year equivalent financial benefit for the trust as £2.6 million. However, this figure was calculated during deployment and go-live phase – realistic full first-year results will be higher. As such, the Trust has projected further savings between £600,000 and £650,000 by increasing feature use to 80% – as this figure rises, further savings will be made, while keeping satisfied patients and staff.
Since ending this project DrDoctor is being supported by Digital Health.London and the NHS Innovation Accelerator and working with two further London Trusts.
Download the full case study below to find out how the partnership delivered an overall DNA reduction of 17.2%, a £2.6 million financial benefit in the first year and 91% patient recommendation rate.
